FindTrial
Sign In

Mean Platelet Volume and TXA2 Levels in Patients With Polycystic Ovary Syndrome (PCOS)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01538602
Enrollment
Unknown
Registered
2012-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2012-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Keywords

PCOS, cardiovascular disorders

Brief summary

Polycystic ovary syndrome (PCOS)is closely associated with insulin resistance and hyperinsulinemia as well as with increased incidence in diabetes, hypertension, dyslipidemia and atherosclerosis. Indeed, subjects with PCOS were reported to carry an increased long-term cardiovascular risk, among others. Aiming to correlate the mean platelet volume, the thromboxane A2 level and the PCOS, an observational study was planned. Clinical evaluation of metabolic outcomes in PCOS patients is compared to a placebo group.

Interventions

None listed

Sponsors

AGUNCO Obstetrics and Gynecology Centre
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 35 Years

Inclusion criteria

* Women fulfilled two out of three diagnostic criteria for PCOS

Exclusion criteria

* Pre-existing secondary endocrine disorders * History of hypertension, diabetes mellitus or cardiovascular disorders * Pharmacologic treatment in the last 6 months before entering the study.

Design outcomes

Primary

MeasureTime frame
Mean platelet volume—
Thromboxane A2—

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026